Role of NK-1 and NK-2 tachykinin receptor antagonism on the growth of human breast carcinoma cell line MDA-MB-231
Authors:
- Mario BigioniMBMario Bigioni
- Alfredina BenzoABAlfredina Benzo
- Clelia IrrissutoCIClelia Irrissuto
- Carlo Alberto MaggiCMCarlo Alberto Maggi
- Cristina GosoCGCristina Goso
- 1 November 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Anti-Cancer Drugs
- Vol. 16 (10) , 1083-1089
Abstract
We demonstrate that neurokinin A (NKA) and substance P (SP) play a role in the proliferation of the estrogen receptor-negative (ER–) cell line MDA-MB-231, a human breast carcinoma expressing both NK-1 and NK-2 receptors. In vitro experiments showed that the specific receptor antagonists MEN 11467 (NK-1) and nepadutant (MEN 11420; NK-2) inhibited tumor cell proliferation, and blocked the stimulatory effect of SP and NKA. Anti-tumoral activity of NK-1 and NK-2 receptor antagonists was demonstrated in nude mice, measuring growth inhibition of MDA-MB-231 tumor cells xenografted s.c. and by using the hollow-fiber assay. In both systems a significant inhibition was found when compounds were administered at 5 mg/kg i.v. every day for 2 weeks. Results obtained from both these models suggest that the in vivo activity of NK-1 and NK-2 antagonists may be a result of a cytostatic effect rather than a cytotoxic effect. Our results suggest that the control of breast carcinoma (ER–) growth by tachykinin receptor antagonists may become a new form of targeted therapy for these human tumors.Keywords
This publication has 13 references indexed in Scilit:
- Microvessel Density as a Prognostic Factor in Women with Breast CancerCancer Research, 2004
- Facilitating Role of Preprotachykinin-I Gene in the Integration of Breast Cancer Cells within the Stromal Compartment of the Bone MarrowCancer Research, 2004
- Neurokinin-1 Receptor Expression and Its Potential Effects on Tumor Growth in Human Pancreatic CancerLaboratory Investigation, 2003
- The Tachykinin Peptide FamilyPharmacological Reviews, 2002
- Neuropeptides as growth factors for normal and cancerous cellsTrends in Endocrinology & Metabolism, 2002
- Increased expression of preprotachykinin-I and neurokinin receptors in human breast cancer cells: Implications for bone marrow metastasisProceedings of the National Academy of Sciences, 2000
- Anti-tumour activity of tachykinin NK1 receptor antagonists on human glioma U373 MG xenograftBritish Journal of Cancer, 2000
- MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonistBritish Journal of Pharmacology, 1998
- Substance‐P receptors in human primary neoplasms: Tumoral and vascular localizationInternational Journal of Cancer, 1995
- New short-chain analogs of a substance-P antagonist inhibit proliferation of human small-cell lung-cancer cellsin vitro and in vivoInternational Journal of Cancer, 1995